ETELCALCETIDE for Hypoparathyroidism secondary: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 6 adverse event reports in the FDA FAERS database where ETELCALCETIDE was used for Hypoparathyroidism secondary.
Most Reported Side Effects for ETELCALCETIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Underdose | 246 | 9.0% | 8 | 16 |
| Shunt stenosis | 202 | 7.4% | 47 | 178 |
| Nausea | 182 | 6.6% | 5 | 14 |
| Product storage error | 148 | 5.4% | 0 | 1 |
| Blood parathyroid hormone increased | 142 | 5.2% | 2 | 7 |
| Hypocalcaemia | 140 | 5.1% | 13 | 31 |
| Shunt occlusion | 126 | 4.6% | 19 | 104 |
| Blood calcium decreased | 119 | 4.3% | 5 | 6 |
| Diarrhoea | 107 | 3.9% | 5 | 13 |
| Vomiting | 102 | 3.7% | 4 | 21 |
| Circumstance or information capable of leading to medication error | 82 | 3.0% | 0 | 0 |
| Death | 78 | 2.8% | 78 | 13 |
| Drug ineffective | 73 | 2.7% | 4 | 2 |
| Fall | 71 | 2.6% | 12 | 62 |
| Cardiac failure | 65 | 2.4% | 29 | 50 |
Other Indications for ETELCALCETIDE
Hyperparathyroidism secondary (1,407)
Product used for unknown indication (1,202)
Hyperparathyroidism (40)
Chronic kidney disease (35)
Blood parathyroid hormone increased (21)
Hyperparathyroidism tertiary (15)
Secondary hyperthyroidism (10)
End stage renal disease (9)
Blood parathyroid hormone abnormal (8)